Samuel Atack Appointed as Operations Director at Stevenage Bioscience Catalyst
We’re delighted to announce that Samuel Atack [...]
We’re delighted to announce that Samuel Atack [...]
Charles Large, Autifony CEO, talks at the 8th Sachs Neuroscience [...]
It’s a pleasure to welcome new occupier [...]
Cellular Origins and Cytiva are collaborating to deliver [...]
Ossianix Receives US$1.26 Grant from The Michael [...]
LifeArc appoints Chief Medical Officer to deliver [...]
GSK announces FIRST trial met its primary [...]
£2.7m infectious disease fund to boost rapid [...]
Revolo Announces New Preclinical Data Supporting Subcutaneous [...]
MFX, Tolemy Bio and Aminoacids.com Partner to [...]